Jürgen Gschwend

Author PubWeight™ 8.01^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.	Eur Urol	2012	1.69
2	Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.	Exp Hematol	2002	1.15
3	Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty.	FASEB J	2004	1.10
4	Pediatric urolithiasis: the current surgical management.	Pediatr Nephrol	2010	0.96
5	Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.	Urol Int	2010	0.94
6	Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer.	Anticancer Res	2013	0.80
7	Nuclear matrix protein 22 for bladder cancer detection: comparative analysis of the BladderChek® and ELISA.	Anticancer Res	2012	0.76
8	Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).	Oncology	2015	0.76